Table 4.

Development vital capacity

				Central diagnoses						Peripheral diagnoses
	Total sample (n = 780)			STI (n = 329)				STH (n = 131)		CIPM (n = 74)			NWA (n = 89)
	VC t0	VC t1	p value	VC t0	VC t1	p value	VC t0	VC t1	p value	VC t0	VC t1	p value	VC t0	VC t1	p value
FAC at t0
0	1500	1800	< 0.001*	1500	1700	0.022*	1200	1700	0.001*	1900	1800	0.195	1300	2000	0.01*
1	1650	2000	0.079*	1900	2000	0.475*	1450	2400	0.052*	1300	1700	0.500
2	1500	1500	0.047*	1200	1200	0.291*	1800	2350	0.098*	1300	1300	1.000
3	1900	2000	0.832*	1600	1650	0.385*	1450	2350	0.219*	2000	2200	0.609
4	2000	2300	0.028*	2050	2150	0.559*	2200	2200	1.000*	NA	NA	NA
5	2700	2800	0.062*	2700	2500	0.488*	2700	2850	0.195*	3900	3200	1.000

FAC Functional Ambulation Categories, VC Median vital capacity in Cubic centimeter (ccm), t0- start of inpatient rehabilitation, t1- end of inpatient rehabilitation, p value- derived from paired Wilcoxon test- *p < 0.05, STI ischemic stroke, STH hemorrhagic stroke, CIPM Critical Illness Polyneuropathy or –Myopathy, NWA patients who did not reach walking ability neither at the beginning nor at the end of rehabilitation- this subgroup n = 89 is composed as follows 45(STI) + 24(STH) + 10(CIPM) + 10(other neurological diagnosis)